Form 4 for IRWD IRONWOOD PHARMACEUTICALS INC
Accepted 2022-01-21 00:00:00 ET · period of report 2022-01-19 · accession 0001104659-22-006551 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-21 | 2022-01-19 | IRWD | Shetzline Michael | CMO, SVP, Head-Res, Drug | A - Grant | $0.00 | +29.3K | 213.0K | +16% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Class A Common Stock | 2022-01-19 | A | A | 29,326 | $0.00 | 212,987 | D | — | — |